Abbott Laboratories (rights to Gabitril)
1998
FOUNDED
M&A
STATUS
Asset Purch.
LATEST DEAL TYPE
1
FINANCING ROUNDS
Description
A drug manufacturing rights. The drug is a treatment for partial seizures related to epilepsy enabling patience in reducing the frequency of partial seizures when added to an existing regimen of at least one other antiepilepsy drug.
Website
Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Office
- Chicago, IL
- United States
Abbott Laboratories (rights to Gabitril) Valuation and Funding
| Deal Type | Date | Amount | Post-Val | Valuation/ EBITDA |
Debt | Status |
|---|
This information is reserved for PitchBook Platform users. To explore Abbott Laboratories (rights to Gabitril)‘s full profile, request access.
Request full access to PitchBookAbbott Laboratories (rights to Gabitril) Former Investors
| Investor Name | Investor Type | Holding | Participating Rounds | Investor Since | Board Seat | Contact Info |
|---|
This information is reserved for PitchBook Platform users. To explore Abbott Laboratories (rights to Gabitril)‘s full profile, request access.
Request full access to PitchBook